Faculty Opinions recommendation of Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis.

Author(s):  
Ming Lim
2021 ◽  
Vol 78 (4) ◽  
pp. 478 ◽  
Author(s):  
Kyla A. McKay ◽  
Emilie Friberg ◽  
Neda Razaz ◽  
Kristina Alexanderson ◽  
Jan Hillert

2019 ◽  
Vol 76 (9) ◽  
pp. 1028 ◽  
Author(s):  
Kyla A. McKay ◽  
Ali Manouchehrinia ◽  
Lindsay Berrigan ◽  
John D. Fisk ◽  
Tomas Olsson ◽  
...  

Neurology ◽  
2019 ◽  
Vol 92 (24) ◽  
pp. e2764-e2773 ◽  
Author(s):  
Kyla A. McKay ◽  
Jan Hillert ◽  
Ali Manouchehrinia

ObjectiveTo evaluate long-term disability progression in pediatric-onset multiple sclerosis (POMS) and compare to adult-onset multiple sclerosis (AOMS).MethodsThis was a retrospective cohort study using prospectively collected clinical information from the Swedish MS Registry. Clinical features were compared and Kaplan-Meier and Cox proportional hazards regression were used to assess the risk of reaching sustained Expanded Disability Status Scale (EDSS) 3, 4, and 6 in POMS (multiple sclerosis [MS] onset <18 years) and AOMS (MS onset ≥18 years).ResultsA total of 12,482 persons were included; 549 (4.4%) were classified as POMS. The POMS cohort took longer to reach all 3 disability milestones from their MS onset, but did so at a younger age than the AOMS cohort. Primary progressive course (hazard ratio [HR] 4.63; 95% confidence interval [CI] 1.46–14.7), higher relapse rate in the first 5 years of disease (HR 5.35; 95% CI 3.37–8.49), and complete remission from the initial relapse (HR 0.41; 95% CI 0.18–0.94) were associated with an altered risk of progression to EDSS 4 among POMS cases. The same pattern emerged for the risk of reaching EDSS 3 and 6.ConclusionsPatients with pediatric-onset MS follow a distinctive clinical course, which should be considered in the treatment and management of the disease.


Sign in / Sign up

Export Citation Format

Share Document